Mediclinic Middle East announces acquisition of Ayadi Home Healthcare

Sponsored Content

Mediclinic Middle East, one of the UAE’s leading private hospital groups with seven hospitals and more than 20 outpatient clinics across Dubai, Abu Dhabi and Al Ain, on Monday announced the acquisition of Ayadi Home Healthcare (Ayadi), which provides home healthcare services to patients in Abu Dhabi and Al Ain.

An opportunity to manage patient care in the home setting had been identified by Mediclinic Middle East, and this acquisition allows the company to further action its strategy of expansion along the continuum of care.  It takes place shortly after Mediclinic Middle East took 100% control of Bourn Hall Fertility Centre in the MENA region, one of the world’s most recognised names in IVF and infertility treatments.

Ayadi, with a team of medical professionals including doctors, nurses and therapists, currently provides home healthcare services including respiratory care, medicine administration, wound and ulcer care, chronic disease management, nutritional therapy, total parenteral nutrition, physical therapy and occupational therapy.  Through this acquisition, Mediclinic Middle East will be able to continue to support its patients who have left the traditional hospital setting, or who are unable/unwilling to visit a medical facility in person.

David Hadley, Chief Executive Officer of Mediclinic Middle East, said:  “Covid-19 has instigated a paradigm shift within the UAE with regard to the point of delivery of healthcare services. As Mediclinic responds to this outmigration of care and continues to expand its service offerings across the care continuum, we are delighted to sign this agreement to acquire Ayadi, one of the leading players in the home healthcare market in Abu Dhabi and Al Ain.” 

About Mediclinic Middle East

Mediclinic Middle East is part of Mediclinic International plc, a London Stock Exchange (LSE)-listed private healthcare group with three operating divisions in Switzerland, Southern Africa (South Africa and Namibia) and the United Arab Emirates. Mediclinic International also holds a 29.9% interest in Spire Healthcare Group plc, a LSE-listed and UK-based private healthcare group.

The foundation of Mediclinic lies in the application of rigorous science to improve the lives of patients, through the use of state-of-the-art treatments and technologies to care for patients in an evidence-based environment.

Mediclinic Middle East operates seven hospitals and more than 20 clinics in the UAE with over 900 inpatient beds.

For further information please contact Arun Avamil at info[at]mediclinic.ae.